{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:01:38Z","timestamp":1790226098163,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013043","name":"Yale Center for Clinical Investigation","doi-asserted-by":"crossref","award":["K01MH092681"],"award-info":[{"award-number":["K01MH092681"]}],"id":[{"id":"10.13039\/100013043","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013043","name":"Yale Center for Clinical Investigation","doi-asserted-by":"crossref","award":["K01MH091354"],"award-info":[{"award-number":["K01MH091354"]}],"id":[{"id":"10.13039\/100013043","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nancy Taylor Foundation","award":["UL1RR024139"],"award-info":[{"award-number":["UL1RR024139"]}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center for Post Traumatic Stress Disorder","award":["2P50AA012879"],"award-info":[{"award-number":["2P50AA012879"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.biopsych.2014.06.024","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T09:47:47Z","timestamp":1404985667000},"page":"266-275","source":"Crossref","is-referenced-by-count":94,"title":["In Vivo Ketamine-Induced Changes in [ 11 C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5"],"prefix":"10.1016","volume":"77","author":[{"given":"Christine","family":"DeLorenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"DellaGioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Sanacora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadi","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofeng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. John","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin V.","family":"Parsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Esterlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2014.06.024_bib1","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/j.1530-0277.2012.01776.x","article-title":"Nucleus accumbens mGluR5-associated signaling regulates binge alcohol drinking under drinking-in-the-dark procedures","volume":"36","author":"Cozzoli","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2014.06.024_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.fbp.0000081783.35927.8f","article-title":"Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: Behavioural characterization and implications for the treatment of CNS disorders","volume":"14","author":"Spooren","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1073\/pnas.1210984110","article-title":"Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography","volume":"110","author":"Akkus","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.06.024_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/appi.ajp.2011.09111607","article-title":"Reduced metabotropic glutamate receptor 5 density in major depression determined by [11C]ABP688 PET and postmortem study","volume":"168","author":"Deschwanden","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2008.10.025","article-title":"Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: Relationship to treatment resistance in major depressive disorder","volume":"65","author":"Price","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","article-title":"Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders","volume":"68","author":"Y\u00fcksel","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1399-5618.2012.01033.x","article-title":"Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: A meta-analysis","volume":"14","author":"Gigante","year":"2012","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2014.06.024_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","article-title":"Glutamate and depression: Clinical and preclinical studies","volume":"1003","author":"Paul","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2014.06.024_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: Where do we go from here?","volume":"72","author":"aan Het Rot","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib12","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.biopsych.2013.01.038","article-title":"Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression","volume":"74","author":"Niciu","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib13","article-title":"Neurocognitive effects of ketamine in treatment-resistant major depression: Association with antidepressant response [published online ahead of print Sep 11]","author":"Murrough","year":"2013","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.biopsych.2014.06.024_bib14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2014.06.024_bib18","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.06.024_bib19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.biopsych.2011.11.006","article-title":"(1)H-[(1)(3)C]-nuclear magnetic resonance spectroscopy measures of ketamine\u2019s effect on amino acid neurotransmitter metabolism","volume":"71","author":"Chowdhury","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/mp.2011.171","article-title":"Ketamine effects on brain GABA and glutamate levels with 1H-MRS: Relationship to ketamine-induced psychopathology","volume":"17","author":"Stone","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.biopsych.2014.06.024_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/ALN.0b013e31826a0db3","article-title":"Effect of subanesthetic ketamine on intrinsic functional brain connectivity: A placebo-controlled functional magnetic resonance imaging study in healthy male volunteers","volume":"117","author":"Niesters","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2014.06.024_bib24","doi-asserted-by":"crossref","first-page":"e44799","DOI":"10.1371\/journal.pone.0044799","article-title":"Ketamine decreases resting state functional network connectivity in healthy subjects: Implications for antidepressant drug action","volume":"7","author":"Scheidegger","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.biopsych.2014.06.024_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2967\/jnumed.112.111922","article-title":"Imaging changes in synaptic acetylcholine availability in living human subjects","volume":"54","author":"Esterlis","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2014.06.024_bib26","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/npp.2008.104","article-title":"Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects","volume":"34","author":"Frankle","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.06.024_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/mp.2012.109","article-title":"Striatal dopamine release in schizophrenia comorbid with substance dependence","volume":"18","author":"Thompson","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/mp.2013.9","article-title":"Imaging dopamine transmission in the frontal cortex: A simultaneous microdialysis and [(11)C]FLB 457 PET study","volume":"19","author":"Narendran","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/npp.2009.189","article-title":"Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers","volume":"35","author":"Guo","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.06.024_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jcbfm.2012.195","article-title":"Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans","volume":"33","author":"Sullivan","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.06.024_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2967\/jnumed.112.107995","article-title":"18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: A first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry","volume":"54","author":"Wong","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2014.06.024_bib32","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/jcbfm.2011.105","article-title":"In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688","volume":"31","author":"DeLorenzo","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.06.024_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biopsych.2010.12.023","article-title":"Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11C] ABP688 and N-acetylcysteine challenge","volume":"69","author":"Miyake","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.nucmedbio.2010.04.107","article-title":"Evaluation of a bolus\/infusion protocol for 11C-ABP688, a PET tracer for mGluR5","volume":"37","author":"Burger","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib35","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2967\/jnumed.108.056291","article-title":"Metabotropic glutamate subtype 5 receptors are quantified in the human brain with a novel radioligand for PET","volume":"49","author":"Brown","year":"2008","journal-title":"Jm Nucl Med"},{"key":"10.1016\/j.biopsych.2014.06.024_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1999","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.biopsych.2014.06.024_bib40","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/1097-4679(198409)40:5<1270::AID-JCLP2270400526>3.0.CO;2-7","article-title":"Factor structure of the profile of mood states (POMs), two partial replications","volume":"40","author":"Norcross","year":"1984","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/syn.21656","article-title":"Studies of the metabotropic glutamate receptor 5 radioligand [(1)(1)C]ABP688 with N-acetylcysteine challenge in rhesus monkeys","volume":"67","author":"Sandiego","year":"2013","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2014.06.024_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nucmedbio.2013.09.008","article-title":"Binding potential of (E)-[(11)C]ABP688 to metabotropic glutamate receptor subtype 5 is decreased by the inclusion of its (11)C-labelled Z-isomer","volume":"41","author":"Kawamura","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib43","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00259-010-1723-7","article-title":"In vivo positron emission tomography imaging with [(11)C]ABP688: Binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons","volume":"38","author":"DeLorenzo","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopsych.2014.06.024_bib44","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2967\/jnumed.107.039578","article-title":"Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: Assessment of methods","volume":"48","author":"Treyer","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2014.06.024_bib45","first-page":"3281","article-title":"Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT","volume":"5","author":"Carson","year":"2003","journal-title":"Nuclear Science Symposium Conference Record, 2003 IEEE"},{"key":"10.1016\/j.biopsych.2014.06.024_bib46","doi-asserted-by":"crossref","first-page":"16720","DOI":"10.1073\/pnas.1208494109","article-title":"NMDA receptor function in large-scale anti-correlated neural systems with implications for cognition and schizophrenia","volume":"109","author":"Anticevic","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.06.024_bib47","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/mp.2012.194","article-title":"Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans","volume":"18","author":"Driesen","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2014.06.024_bib50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0022-3565(25)11430-4","article-title":"Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors","volume":"260","author":"Oye","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2014.06.024_bib51","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/j.1530-0277.2012.01815.x","article-title":"Positron emission tomography shows elevated cannabinoid CB (1) receptor binding in men with alcohol dependence","volume":"36","author":"Neumeister","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2014.06.024_bib52","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/jcbfm.2011.55","article-title":"Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography","volume":"31","author":"Rusjan","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.06.024_bib53","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/jcbfm.2009.195","article-title":"Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans","volume":"30","author":"Gallezot","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.06.024_bib54","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2967\/jnumed.106.038075","article-title":"Optimal metabolite curve fitting for kinetic modeling of 11C-WAY-100635","volume":"48","author":"Wu","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2014.06.024_bib55","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/jcbfm.2011.105","article-title":"In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688","volume":"31","author":"DeLorenzo","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.06.024_bib56","series-title":"SPIE Medical Imaging","first-page":"72592W","article-title":"A new method for assessing PET-MRI coregistration","author":"DeLorenzo","year":"2009"},{"key":"10.1016\/j.biopsych.2014.06.024_bib57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.06.024_bib58","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.nucmedbio.2007.07.009","article-title":"Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB","volume":"34","author":"Patel","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib59","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.06.024_bib60","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.jcbfm.9600607","article-title":"Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: Quantitative modeling and test-retest reproducibility","volume":"28","author":"Hirvonen","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2014.06.024_bib61","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/syn.21542","article-title":"Test-retest stability of cerebral mGluR(5) quantification using [(1)(1)C]ABP688 and positron emission tomography in rats","volume":"66","author":"Elmenhorst","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2014.06.024_bib62","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.nucmedbio.2007.07.009","article-title":"Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB","volume":"34","author":"Patel","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib63","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroimage.2013.05.006","article-title":"A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066\u2014estimating occupancy in the absence of a reference region","volume":"82","author":"K\u00e5gedal","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.06.024_bib64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1523\/JNEUROSCI.0186-13.2014","article-title":"Neuronal phenotype dependency of agonist-induced internalization of the 5-HT(1A) serotonin receptor","volume":"34","author":"Bouaziz","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2014.06.024_bib65","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.neuroscience.2007.11.024","article-title":"Unchanged density of 5-HT(1A) autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine","volume":"151","author":"Riad","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2014.06.024_bib66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0026-895X(25)09230-2","article-title":"Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro","volume":"50","author":"Berry","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib67","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1124\/mol.104.001495","article-title":"Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons","volume":"66","author":"Macey","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib68","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.154.6.805","article-title":"Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers","volume":"154","author":"Breier","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2014.06.024_bib69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0924-977X(96)00039-9","article-title":"Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)","volume":"7","author":"Vollenweider","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2014.06.024_bib70","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00213-009-1758-2","article-title":"The interactive effects of ketamine and nicotine on human cerebral blood flow","volume":"208","author":"Rowland","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2014.06.024_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneumeth.2004.07.014","article-title":"Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans","volume":"142","author":"Ardekani","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.biopsych.2014.06.024_bib72","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00004728-199803000-00032","article-title":"Enhancement of MR images using registration for signal averaging","volume":"22","author":"Holmes","year":"1998","journal-title":"J Comput Assist Tomogr"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314005010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314005010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T18:46:06Z","timestamp":1746297966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322314005010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0006322314005010"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2014.06.024","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}